Have been on Olaparib for 22 months so far. 400 mg 2x daily. BRCA2+. MSS and low tumor burden rules out Keytruda combo, or by itself, as an effective option.
PSA had been undetectable for 18 months before rising to 1.11 so far. Had Auximin scan 2 days ago. Just one small spot on lung found. Radiologist said this could be the cause of PSA rise, and should be zapped.
Finally having 18F PYL PSMA scan next week as part of trial at Stony Brook. Have been searching for past several months. NIH and Weill Cornell applications were unsuccessful. Trial will compare the 2 scans, and expect PSMA to be more sensitive. Hopefully will not find much more than Auximin but won't be surprised if it does.
Side effects of long term use of Olaparib have been anemia, constipation, memory issues, headaches and fatigue; all tolerable. Especially since it has been very effective.
Written by
HopingForTheBest1
To view profiles and participate in discussions please or .
Multiple posts on re challenging with a second PARPi which is FDA approved for ovarian cancer. PARPi’s were trialled in OVC first, they are about 7 years ahead of Prostate cancer and for someone like yourself who had such a fantastic response it may be an option after tackling the small spots which are causing your PSA to rise.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.